Clin2
NCT06653686Possibly a fitNot yet recruiting

Heat therapy for stubborn gout

Refractory Gout

Treatments studied

Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.

This study tests whether applying heat (thermotherapy) can help people with difficult-to-treat gout. It aims to reduce gout attacks and improve symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
128 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old.
  • You have refractory gout — meaning standard treatments aren't working well enough, or you have frequent flares or tophi.
  • You've had at least 3 gout flares in the last 12 months.
  • You have not had an acute gout flare in the past 2 weeks.
  • You don't have other causes of joint pain (like rheumatoid arthritis) or serious health conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07587684Recruiting· Phase 1
Testing IN026 for Hard-to-Treat Gout

This study tests a new drug called IN026 for people with refractory gout—gout that doesn't respond well to current treatments and causes severe symptoms. The goal is to see if IN026 can lower uric acid levels and reduce gout attacks.

Wuhan
NCT07362355Recruiting· Phase 2
New gout pill combined with febuxostat for high uric acid

This trial tests an experimental tablet (SHR4640) added to the standard gout medicine febuxostat (40 mg daily) for people whose uric acid remains too high despite febuxostat alone. The goal is to see if the combination lowers uric acid more effectively and safely.

Shanghai, Shanghai Municipality
NCT07369622Not yet recruiting· Phase 4
Gene-guided gout treatment for safer, effective care

This study tests whether a genetic test can help doctors choose the safest and most effective gout medication. It aims to prevent severe allergic reactions by personalizing treatment based on your genes.

NCT07842497Not yet recruiting· Phase 2
New treatment for sudden gout attacks

This study tests a new medication for people with sudden gout flare-ups who haven't gotten relief from or can't take the usual treatments. It may help reduce pain and inflammation faster, and you'll receive either the study drug or a placebo (inactive treatment) along with standard care.

Jing’an, Shanghai Municipality
NCT04875702Recruiting· Phase 4
Compare urate targets to reduce gout attacks or symptoms

This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.

South Birmingham, Alabama
NCT07498647Not yet recruiting· Phase 2
Testing a new tablet for gout and high uric acid

This trial tests an investigational tablet called BR2251 to see if it can lower uric acid levels in people with gout and hyperuricemia (too much uric acid in the blood). If you qualify, you may get a new treatment that could help prevent painful gout attacks.

Hear when a new Refractory Gout trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.